The expression of SLC31A1 is associated with a variety of cancers, including lung cancer (Wang et al., 2021), pancreatic cancer (Yu et al., 2019), and ovarian cancer (Wu et al., 2021). Here, SLC31A1 is linked to ovarian carcinoma.